Literature DB >> 18097021

Caspase-independent cell death by CD300LF (MAIR-V), an inhibitory immunoglobulin-like receptor on myeloid cells.

Ismail Can1, Satoko Tahara-Hanaoka, Kaori Hitomi, Takako Nakano, Chigusa Nakahashi-Oda, Naoki Kurita, Shin-ichiro Honda, Kazuko Shibuya, Akira Shibuya.   

Abstract

The myeloid-associated Ig-like receptor family (CD300) consists of nine activating or inhibitory cell surface receptors preferentially expressed on myeloid cells and are encoded by the genes in a small cluster on mouse chromosome 11. One of the receptors, CD300LF (MAIR-V), has a long cytoplasmic tail containing two consensus ITIMs and an immunoreceptor tyrosine-based switching motif, suggesting that CD300LF regulates the activation of myeloid cells. However, the functional characteristics of this receptor are still incompletely understood. In this study, we demonstrate that cross-linking CD300LF with anti-CD300LF mAb induced cell death in peritoneal macrophages as well as in several transfectants expressing CD300LF. CD300LF-mediated cell death was dependent on the cytoplasmic region but did not require an ITIM or immunoreceptor tyrosine-based switching motif. Scanning electron microscopy revealed a loss of blebs from the surface of the dead cells mediated by CD300LF, a morphological feature similar to that observed in apoptotic cells. However, CD300LF-mediated cell death was not inhibited by a caspase inhibitor, N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone, or autophagy inhibitors, 3-methyladenine or N-acetyl-L-cystein. Moreover, the splicing isoform of a transcription factor, X-box binding protein-1, which is produced in dead cells as a response to endoplasmic reticulum stress, was not detected. Together, these results indicate that CD300LF mediates caspase and endoplasmic reticulum stress-independent cell death by a novel mechanism.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18097021     DOI: 10.4049/jimmunol.180.1.207

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Immune receptor expressed on myeloid cells 1 (IREM-1) inhibits B cell activation factor (BAFF)-mediated inflammatory regulation of THP-1 cells through modulation of the activities of extracellular regulated kinase (ERK).

Authors:  S-M Lee; Y-P Nam; K Suk; W-H Lee
Journal:  Clin Exp Immunol       Date:  2010-09       Impact factor: 4.330

Review 2.  The CD300 molecules: an emerging family of regulators of the immune system.

Authors:  Francisco Borrego
Journal:  Blood       Date:  2013-01-04       Impact factor: 22.113

3.  [Characteristics of peripheral rheograms following thermal provocation in normal and pathologic pregnancy].

Authors:  A Feiks; C Nowotny; W Gruber
Journal:  Geburtshilfe Frauenheilkd       Date:  1988-09       Impact factor: 2.915

4.  Cutting edge: mouse CD300f (CMRF-35-like molecule-1) recognizes outer membrane-exposed phosphatidylserine and can promote phagocytosis.

Authors:  Seung-Chul Choi; Venkateswara R Simhadri; Linjie Tian; Aleksandra Gil-Krzewska; Konrad Krzewski; Francisco Borrego; John E Coligan
Journal:  J Immunol       Date:  2011-08-24       Impact factor: 5.422

5.  Identification and Characterization of CD300H, a New Member of the Human CD300 Immunoreceptor Family.

Authors:  Kouta Niizuma; Satoko Tahara-Hanaoka; Emiko Noguchi; Akira Shibuya
Journal:  J Biol Chem       Date:  2015-07-28       Impact factor: 5.157

6.  CD300lf Conditional Knockout Mouse Reveals Strain-Specific Cellular Tropism of Murine Norovirus.

Authors:  Vincent R Graziano; Mia Madel Alfajaro; Cameron O Schmitz; Renata B Filler; Madison S Strine; Jin Wei; Leon L Hsieh; Megan T Baldridge; Timothy J Nice; Sanghyun Lee; Robert C Orchard; Craig B Wilen
Journal:  J Virol       Date:  2021-01-13       Impact factor: 5.103

7.  Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor.

Authors:  Chigusa Nakahashi-Oda; Satoko Tahara-Hanaoka; Masamichi Shoji; Yasushi Okoshi; Takako Nakano-Yokomizo; Nobuhiro Ohkohchi; Teruhito Yasui; Hitoshi Kikutani; Shin-ichiro Honda; Kazuko Shibuya; Shigekazu Nagata; Akira Shibuya
Journal:  J Exp Med       Date:  2012-07-23       Impact factor: 14.307

8.  DlgR2 knockdown boosts dendritic cell activity and inhibits hepatocellular carcinoma tumor in-situ growth.

Authors:  Zhen Lu; Yun-Hong Xia; Min Zhao; Bing Zhang; Wen-Ting Dai; Lu Ding; Li-Xia Hu; Jin-Ling Bi; Guo-Lin Jiang
Journal:  Oncotarget       Date:  2017-07-05

9.  Regulation of Immune Responses by the Activating and Inhibitory Myeloid-Associate Immunoglobuline-Like Receptors (MAIR) (CD300).

Authors:  Akira Shibuya; Chigusa Nakahashi-Oda; Satoko Tahara-Hanaoka
Journal:  Immune Netw       Date:  2009-04-30       Impact factor: 6.303

10.  Negative regulation of autoimmune demyelination by the inhibitory receptor CLM-1.

Authors:  Hongkang Xi; Kenneth J Katschke; Karim Y Helmy; Paige A Wark; Noelyn Kljavin; Hilary Clark; Jeffrey Eastham-Anderson; Theresa Shek; Merone Roose-Girma; Nico Ghilardi; Menno van Lookeren Campagne
Journal:  J Exp Med       Date:  2009-12-28       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.